Why Is Small-Cap Cancer-Focused Zentalis Pharma Stock Trading Lower On Tuesday?
Zentalis Pharmaceuticals announced the FDA's partial clinical hold on azenosertib studies due to recent patient deaths.
Top 3 Energy Stocks Which Could Rescue Your Portfolio In June
The most oversold stocks in the energy sector presents an opportunity to buy into undervalued companies. The RSI…
New Windows Vulnerability Poses Major Threat: Hackers Can Infect PCs Via Wi-Fi
New security flaw discovered in Windows allows hackers to infect PCs over Wi-Fi without user interaction, posing a significant threat. Microsoft has already patched, but potential for exploitation remains.
Nvidia, CrowdStrike And 2 Other Stocks Insiders Are Selling
The Nasdaq 100 closed higher by more than 1% on Monday. Investors, meanwhile, focused on some notable insider…
NextEra Energy, Lennar And Other Big Stocks Moving Lower In Tuesday’s Pre-Market Session
U.S. stock futures were mixed this morning, with the Nasdaq futures gaining around 0.2% on Tuesday. Shares of…
Toronto Zoo Has Selected Everbridge To Help Safeguard Both Guests And Staff
Canada's largest zoo deploys Everbridge Mass Notification solution to rapidly communicate with visitors and staff during an emergencyEverbridge, Inc. (NASDAQ:EVBG), the global leader in critical event management (CEM)
What’s Happening With Tobacco Major Philip Morris Shares On Tuesday?
Following a subpoena from D.C. authorities, Philip Morris has suspended online sales of its Zyn nicotine pouches amid an investigation into compliance with local flavored product bans.
‘Trump Coin’ DJT Allegedly Tied To Donald Trump Causes Havoc, Other Trump Meme Coins Plummet 30%
“Trump Coin,” a cryptocurrency reportedly directly linked to members of the Trump campaign, continues causing havoc in the crypto space and has caused other Trump-related meme coins to sell off.
Zevra Therapeutics Selects Orsini As The Specialty Pharmacy Provider For OLPRUVA
Orsini Specialty Pharmacy (Orsini), and Zevra Therapeutics, Inc. (NASDAQ:ZVRA) (Zevra) today announced that Orsini is now the pharmacy partner for OLPRUVA® (sodium phenylbutyrate) for oral suspension. OLPRUVA®
CEL-SCI Presents Head & Neck Cancer Data At IDDST Annual Congress In Budapest: Risk Of Death Cut In Half For Patients Treated With Multikine In The Target Population
Multikine significantly increases overall survival in patients with low levels of tumor cell PD-L1 expression in contrast to approved checkpoint inhibitors73% survival for Multikine vs 45% in the control arm at 5